ROBERT S. LASNIK, District Judge.
This matter comes before the Court on "Defendant Dr. El Khoury's Motion for Attorney's Fees and Costs Pursuant to Fed. R. Civ. P. 54(d)(2)." (Dkt. #295). Defendant seeks an award of $1,754,640 for attorney's fees and $61,811.44 for related nontaxable costs and expenses incurred in defending against plaintiff's claims of fraud, breach of fiduciary duty, undue influence and conversion. Plaintiff's opposition was untimely, and has not been considered.
Having reviewed the memoranda, declarations and exhibits submitted by the parties, the Court finds as follows:
Defendant argues that he is entitled to an award of fees and costs under the various contracts through which he purchased Interplexus and Diagnos-Techs. The relevant contracts in this case do not, however, provide for the requested attorney's fees. The Stock Purchase Agreements for the sale of Interplexus and Diagnos-Techs do not contemplate attorney's fees. Dkt. #21 at 11-20 (Diagnos-Techs Stock Purchase Agreement); Trial Ex. #33 (Interplexus Stock Purchase Agreement). Although the Stock Pledge Agreements for both companies contain identical attorney's fees provisions, the provisions do not apply in this case. The relevant section reads:
Dkt. #21 at 53, 60. The Court interprets the provision to apply in the case of default on payment or a failure to perform under the contract. Since defendant's attorney's fees do not relate to a default or a failure to perform, the Stock Pledge Agreements are not applicable. Similarly, the attorney's fees provision in the Promissory Note also provides for fees only after a default.
For all of the foregoing reasons, "Defendant Dr. El Khoury's Motion for Attorney's Fees and Costs Pursuant to Fed. R. Civ. P. 54(d)(2)" is DENIED.